(Q37832285)

24 August 2017

1 reference

title

Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications (English)

1 reference

chronic renal insufficiency

24 August 2017

main subject

1 reference

based on heuristic

inferred from title

author name string

Matthew J Damasiewicz

series ordinal

1

1 reference

24 August 2017

Nigel D Toussaint

series ordinal

2

1 reference

24 August 2017

Kevan R Polkinghorne

series ordinal

3

1 reference

24 August 2017

publication date

1 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

16

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

261-268

1 reference

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Vascular calcification and ESRD: a hard target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Structural and biochemical properties of fibroblast growth factor 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Klotho converts canonical FGF receptor into a specific receptor for FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Clinical relevance of FGF-23 in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Hypophosphatemia: an update on its etiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Proximal tubular handling of phosphate: A molecular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Regulation of fibroblast growth factor-23 signaling by klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Severely reduced production of klotho in human chronic renal failure kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Initial FGF23-mediated signaling occurs in the distal convoluted tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

How fibroblast growth factor 23 works

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Bone formation regulates circulating concentrations of fibroblast growth factor 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Relationship between circulating FGF23 and total body atherosclerosis in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Phosphorus binders and survival on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01443.X

10.1111/J.1440-1797.2011.01443.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference